封面
市場調查報告書
商品編碼
1914520

化妝品環肽成分市場:全球預測(2026-2032 年),按肽類型、等級、形態、應用、最終用戶和分銷管道分類

Cosmetic Cyclic Peptide Raw Materials Market by Peptide Type, Grade, Form, Application, End User, Distribution Channel - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,化妝品環肽原料市場規模將達到 1.647 億美元,到 2026 年將成長至 1.7508 億美元,到 2032 年將達到 2.787 億美元,複合年成長率為 7.80%。

關鍵市場統計數據
基準年 2025 1.647億美元
預計年份:2026年 1.7508億美元
預測年份 2032 2.787億美元
複合年成長率 (%) 7.80%

了解為什麼環肽成分因其穩定性、定向和與先進配方的兼容性,在化妝品行業中變得越來越重要。

環肽已成為化妝品科學領域一類獨特的活性成分,因其結構穩定性、靶向定向以及與先進遞送系統的兼容性而備受青睞。這些分子以主鏈環化或側鏈連接為特徵,與線性胜肽相比,具有許多配方優勢,例如更強的抗酶分解能力和更高的受體結合力。因此,環肽的應用前景十分廣闊,從調節表面受體到支持細胞訊號傳導,尤其是在需要長期維持胜肽完整性的情況下。

探索正在改變化妝品中環肽成分的來源、合成和應用的科學、監管和消費趨勢的融合。

一系列變革正在重新定義環肽在化妝品領域的構思、生產和應用方式。合成化學的進步(例如,先進的固相合成通訊協定、化學選擇性環化技術和改進的純化技術)降低了技術門檻,使得在適用於化妝品應用的規模上穩定生產複雜的環狀結構成為可能。同時,高解析度質譜和正交層析法等分析技術提高了品質保證水平,使供應商能夠提供詳細的雜質和胜肽表徵數據,這些數據對於符合法規要求和配方穩定性至關重要。

評估美國關稅政策變化對特種原料採購和供應鏈韌性的更廣泛營運和採購影響

美國貿易政策的轉變以及2025年前的關稅調整,為包括環肽原料在內的特種原料的全球採購管道帶來了特定的摩擦。某些化學中間體和成品胜肽的進口關稅提高,增加了依賴國際供應的買家的到岸成本。這促使整個價值鏈進行策略調整。一些買家正在加快尋找低關稅地區的替代供應商,而另一些買家則在重新談判供應契約,以納入關稅轉嫁條款或修改交貨條款來降低風險。

解讀應用需求、胜肽結構、最終用戶要求、等級分類、物理形態和分銷管道如何共同影響籌資策略和規格製定。

細分市場層面的趨勢揭示了價值領域和技術風險集中的方面,這些方面涵蓋了應用、胜肽結構、最終用戶、等級預期、劑型和通路。針對特定應用的開發正在評估環狀胜肽在抗衰老齡化、生髮、保濕、美白和紫外線防護方面的應用,配方師優先考慮穩定性並針對每個應用場景進行定向。肽結構至關重要。多硫鍵和單硫鍵連接的胜肽因其分子內交聯賦予構象穩定性而被選用。同時,頭尾環化、側鏈環化和胜肽鏈交聯設計被用來調整受體親和性、蛋白酶抗性和細胞滲透性。這些分子的選擇直接影響合成的複雜性和分析要求,因此採購團隊必須使技術規格與預期應用效能相符。

了解世界各地監管嚴格程度、製造能力和消費者偏好的區域差異如何影響採購和產品開發策略

區域趨勢在塑造環肽成分的供應商生態系統、監管要求和產品定位方面發揮著至關重要的作用。在美洲,創新中心和強大的契約製造支持新型胜肽化學在化妝品配方中的快速應用。法規結構強調成分安全性和標籤透明度,鼓勵供應商優先提供詳細的分析文件和穩定性數據。區域內的南北供應關係也至關重要,因為與較長的國際採購鏈相比,從專業製造商和研發公司採購可以縮短開發週期。

在選擇能夠可靠地為化妝品應用提供高品質環肽原料的供應商時,評估供給能力、透過創新實現差異化以及夥伴關係模式非常重要。

供應商和服務供應商之間的競爭反映了其能力的頻譜,涵蓋了從專業胜肽合成到垂直整合的開發和品質保證服務等各個方面。擁有深厚合成技術和全面分析平台的成熟胜肽生產商,在服務需要可追溯性和一致性能數據的製劑開發人員方面,正佔據越來越有利的地位。同時,靈活的細分市場供應商和受託研究機構正在透過提供客製化環化方法、快速原型製作和小批量生產服務來縮小差距,從而能夠在更短的時間內完成概念驗證測試。

採用整合採購、分析和永續性策略,以降低技術風險並加速肽基化妝品創新成果的商業化。

為了從循環利用的胜肽原料中創造價值,產業領導者應優先考慮整合籌資策略、技術能力和監管前瞻性的方法。首先,建立嚴格的規範模板,記錄特定應用所需的分析特性、雜質容許量和穩定性評估標準。這些模板是供應商選擇的基礎,並能減少規模化生產過程中的不確定性。其次,建立策略供應商關係,包括透明的文件交換、研發和規模化生產過程中的風險共擔,以及能夠應對關稅和物流波動的合約條款。這既能增強韌性,又能確保獲得非商品化的特殊化學品。

了解結合從業者訪談、技術文獻綜述和供應商分析的三角調查方法如何為胜肽成分的可靠見解奠定基礎。

本執行摘要的研究途徑結合了定性研究、技術文獻綜述和系統性的供應商分析,以確保對環肽原料提供全面的觀點。主要數據包括對配方研發科學家、採購經理和契約製造製造商的結構化訪談,以了解實際採購限制和規格要求。技術檢驗包括查閱同行評審期刊、專利申請和監管指南,以確定與化妝品應用相關的最新合成方法、表徵技術和安全性概況。

整合技術、供應鏈和監管要求,以最大限度地發揮環肽的優勢,同時管控營運和合規風險。

環肽為化妝品科學帶來了戰略機遇,其分子層面的優勢,若輔以嚴謹的表徵和恰當的監管定位,便可轉化為差異化的產品宣稱。先進的合成技術、日益提高的分析要求以及不斷變化的貿易趨勢,意味著成功不僅取決於選擇合適的胜肽結構,還取決於選擇能夠提供可驗證且可重複品質的供應商和合作夥伴。隨著相關人員適應關稅主導的供應考量和區域性管理體制,韌性和文件記錄正成為採購和研發部門的兩大優先事項。

目錄

第1章:序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章:按胜肽類型分類的化妝品環肽原料市場

  • 二硫鍵類型
    • 多個二硫鍵
    • 單二硫鍵
  • 顱尾方向環化
  • 側鏈環化
  • 胜肽鏈

第9章:化妝品環肽原料市場(依等級分類)

  • 分析級
  • 化妝品級
  • 醫藥級

第10章:化妝品環肽原料市場(依形態分類)

  • 液體
  • 固體的
    • 結晶質粉末
    • 凍乾粉

第11章:化妝品環肽原料市場(依應用領域分類)

  • 抗衰老
  • 頭髮生長
  • 保濕
  • 美白
  • 紫外線防護

第12章:以最終用戶分類的化妝品環肽原料市場

  • 契約製造
  • 化妝品製造商
  • 皮膚科診所
  • 家用

第13章:化妝品環肽原料市場(依通路分類)

  • 直銷
  • 批發商
  • 線上零售

第14章:化妝品環肽原料市場區域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章:化妝品環肽原料市場(依組別分類)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章:各國化妝品環胜肽原料市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章:美國化妝品環肽成分市場

第18章:中國化妝品環肽原料市場

第19章 競爭情勢

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Bachem Holding AG
  • BASF SE
  • Croda International Plc
  • Evonik Industries AG
  • GenScript Biotech Corporation
  • Givaudan SA
  • Koninklijke DSM NV
  • Merck KGaA
  • PolyPeptide Group Holdings SA
  • The Lubrizol Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-AE420CB152AB

The Cosmetic Cyclic Peptide Raw Materials Market was valued at USD 164.70 million in 2025 and is projected to grow to USD 175.08 million in 2026, with a CAGR of 7.80%, reaching USD 278.70 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 164.70 million
Estimated Year [2026] USD 175.08 million
Forecast Year [2032] USD 278.70 million
CAGR (%) 7.80%

Understand the rising relevance of cyclic peptide raw materials in cosmetics driven by stability, targeted activity, and advanced formulation compatibility

Cyclic peptides have emerged as a distinct class of active ingredients within cosmetic science, valued for their conformational stability, targeted bioactivity, and compatibility with advanced delivery systems. These molecules, characterized by backbone cyclization or side-chain linkages, offer formulation advantages such as increased resistance to enzymatic degradation and enhanced receptor binding compared with linear analogues. As such, formulators are exploring cyclic peptides for applications that range from surface receptor modulation to cellular signaling support, especially where long-term peptide integrity is desirable.

This executive summary synthesizes technical, commercial, and regulatory dimensions relevant to raw-materials stakeholders: procurement officers, formulation scientists, contract manufacturers, and regulatory affairs professionals. It highlights technological inflection points, supply chain dynamics, and segmentation-specific considerations that shape sourcing, specification, and product development strategies. The objective is to equip leaders with a clear view of the operational levers and scientific trends affecting procurement, quality control, and product positioning for cosmetic cyclic peptide ingredients.

Explore the converging scientific, regulatory, and consumer-driven shifts that are transforming sourcing, synthesis, and adoption of cyclic peptide raw materials in cosmetics

A series of transformative shifts is redefining how cyclic peptides are conceived, manufactured, and used in cosmetic applications. Advances in synthetic chemistry-such as refined solid-phase synthesis protocols, chemo-selective cyclization techniques, and improvements in purification-have lowered technical barriers and enabled consistent production of complex cyclic architectures at scales compatible with cosmetic use. Concurrently, analytical capabilities including high-resolution mass spectrometry and orthogonal chromatographic methods have strengthened quality assurance, allowing suppliers to provide detailed impurity profiles and peptide characterization data that are critical for regulatory acceptance and formulation stability.

At the same time, consumer preferences and ingredient transparency demands are steering product development toward well-characterized, efficacious actives with documented mechanisms. This is accelerating collaboration between peptide chemists and dermocosmetic formulators to translate molecular performance into perceptible benefits such as reduced appearance of lines, improved hydration kinetics, and enhanced scalp microenvironment for hair growth. Moreover, sustainability pressures are catalyzing interest in greener synthesis pathways, solvent reduction, and lifecycle thinking. As a result, supply chains are evolving from commodity-driven sourcing toward integrated, traceable partnerships that emphasize reproducibility, quality documentation, and adherence to higher environmental and social governance standards.

Assess the broad operational and sourcing consequences of evolving United States tariff policies on specialty ingredient procurement and supply chain resilience

Trade policy shifts and tariff adjustments in the United States through 2025 have introduced tangible frictions into global procurement channels for specialty ingredients, including cyclic peptide raw materials. Increased import duties on certain classes of chemical intermediates and finished peptide products have elevated landed costs for buyers that rely on international supply. This has prompted strategic adjustments across the value chain: some buyers are accelerating qualification of alternative suppliers in lower-tariff jurisdictions, while others are renegotiating supply contracts to incorporate tariff pass-through clauses or to shift terms of delivery to mitigate exposure.

Beyond direct cost implications, tariffs have affected operational decisions such as inventory planning and the geographic distribution of manufacturing capacity. Firms with vertically integrated or regionally diversified manufacturing networks have greater flexibility to reroute production to minimize tariff impact, whereas smaller purchasers may face extended lead times as procurement cycles adapt. Importantly, tariff-driven supplier diversification also interacts with regulatory compliance: when sourcing moves across borders, documentation requirements and testing expectations can change, requiring additional analytical verification and potential reformulation work. Therefore, the cumulative effect of tariff changes is not limited to pricing alone but extends to resilience planning, supplier engagement, and regulatory due diligence across procurement and product development functions.

Decode how application demands, peptide architectures, end user requirements, grade classifications, physical form factors, and distribution channels jointly shape procurement and specification strategies

Segment-level dynamics reveal where value and technical risk concentrate across applications, peptide architecture, end users, grade expectations, form factors, and channels. For application-focused development, cyclic peptides are being evaluated across anti-aging, hair growth, moisturization, skin lightening, and UV protection contexts, with formulators prioritizing stability and targeted action to align with each use case. Peptide architecture matters greatly; disulfide bonded peptides, which include multi-disulfide and single-disulfide variants, are selected when intramolecular bridges confer conformational integrity, while head-to-tail cyclization, side-chain cyclization, and stapled peptide designs are leveraged to tune receptor affinity, protease resistance, and cellular permeability. These molecular choices directly influence synthesis complexity and analytical requirements, so procurement teams must align technical specifications with intended application performance.

End-user profiles shape procurement cadence and specification rigor. Contract manufacturers typically demand consistent batch-to-batch characterization and robust supply agreements, cosmetic manufacturers prioritize formulation compatibility and safety documentation, dermatology clinics emphasize clinical-grade testing and regulatory provenance, and home-use products require user-friendly stability and packaging formats. Grade differentiation-analytical, cosmetic, and pharmaceutical-creates distinct pathways for quality control and documentation, with analytical grade materials serving as reference standards and pharmaceutical grade necessitating the most stringent GMP-compatible processes. Regarding form, liquid formats offer formulation convenience, while solid formats such as crystalline powder and lyophilized powder provide enhanced shelf stability and transport efficiency; the chosen form impacts handling, reconstitution protocols, and storage. Finally, distribution channels from direct sales and distributor partnerships to online retail determine lead times, logistic touchpoints, and the extent of technical support buyers can expect during qualification and scale-up.

Understand how geographic differences in regulatory rigor, manufacturing capability, and consumer preferences shape sourcing and product development strategies across global regions

Regional dynamics play a decisive role in shaping supplier ecosystems, regulatory expectations, and product positioning for cyclic peptide raw materials. In the Americas, innovation hubs and strong contract manufacturing capabilities support rapid translation of novel peptide chemistries into cosmetic formulations; regulatory frameworks emphasize ingredient safety and labeling transparency, driving suppliers to prioritize detailed analytical documentation and stability data. North-South supply relationships within the region also matter, as sourcing from specialized manufacturers and research-focused companies can shorten development timelines when compared to more extended international procurement chains.

Europe, the Middle East, and Africa present a mixed landscape where regulatory rigor-particularly within the European Union-elevates compliance requirements for cosmetic actives, prompting suppliers to produce thorough toxicological and stability dossiers. This regulatory rigor turbocharges demand for well-documented raw materials and encourages local manufacturing partnerships to ease market entry. The Asia-Pacific region remains a critical node for both manufacturing scale and consumer adoption, with advanced peptide chemistry capabilities coexisting with a highly dynamic retail environment. Here, formulation trends can shift rapidly based on consumer preferences, creating both opportunities and challenges for suppliers aiming to provide differentiated peptide ingredients while meeting diverse regional regulatory and cultural expectations.

Evaluate supplier capabilities, innovation differentiation, and partnership models that determine who can reliably deliver high-quality cyclic peptide raw materials for cosmetic applications

Competitive dynamics among suppliers and service providers reflect a spectrum of capabilities that range from specialized peptide synthesis to vertically integrated development and quality assurance services. Established peptide manufacturers that combine deep synthetic expertise with comprehensive analytical platforms are increasingly positioned to serve formulators who require traceability and consistent performance data. At the same time, agile niche providers and contract research organizations are closing the gap by offering custom cyclization methods, rapid prototyping, and small-batch production services that enable proof-of-concept testing within compressed timelines.

Strategic partnerships are becoming more prevalent: suppliers that offer collaboration across R&D, scale-up, and regulatory support gain preferential consideration from sophisticated cosmetic and dermatology customers. Additionally, investments in automation, continuous synthesis technologies, and greener chemistries are differentiators that signal long-term capacity to meet evolving specification and sustainability expectations. Buyers evaluate potential suppliers not only on price and lead time but also on the depth of analytical documentation, willingness to support application testing, and the presence of robust quality systems that can support cross-border commercialization.

Adopt integrated procurement, analytical, and sustainability strategies to reduce technical risk and accelerate commercialization of peptide-enabled cosmetic innovations

Industry leaders should prioritize an integrated approach that aligns procurement strategy, technical capability, and regulatory foresight to capture value from cyclic peptide raw materials. Begin by establishing rigorous specification templates that codify required analytical attributes, impurity limits, and stability endpoints tied to intended applications; these templates serve as a foundation for supplier qualification and reduce ambiguity during scale-up. Next, cultivate strategic supplier relationships that include transparent documentation exchange, joint risk-sharing on R&D scale-up, and contractual terms that address tariff and logistic volatility. Doing so will create resilience while preserving access to specialized chemistries that are not commoditized.

Investments in in-house or partnered analytical capacity pay dividends by accelerating qualification cycles and enabling rapid troubleshooting of formulation interactions. Leaders should also sequence sustainability targets into sourcing decisions, exploring greener solvents, solvent recycling, and process intensification approaches that reduce environmental footprint without compromising product quality. Finally, align commercialization strategies with evidence-based claims by investing in clinical or consumer testing where appropriate, and ensure regulatory teams are engaged early to navigate regional requirements. Together, these actions will reduce technical risk, shorten time-to-market, and enable premium positioning for products that leverage cyclic peptide actives.

Learn how a triangulated methodology combining practitioner interviews, technical literature review, and supplier profiling underpins reliable insights into peptide raw materials

The research approach underpinning this executive synthesis combines primary qualitative inquiry, technical literature review, and systematic supplier profiling to ensure a well-rounded perspective on cyclic peptide raw materials. Primary inputs included structured interviews with formulation scientists, procurement leads, and contract manufacturers to capture real-world sourcing constraints and specification expectations. Technical validation involved reviewing peer-reviewed journals, patent filings, and regulatory guidances to confirm contemporary synthesis methods, characterization techniques, and safety considerations relevant to cosmetic use.

Complementing this, supplier profiling drew on public filings, product technical data sheets, and validated third-party analytical reports to assess capabilities and documentation practices. Throughout the process, cross-validation between primary interviews and secondary technical sources was used to resolve discrepancies and to highlight consensus versus areas of ongoing debate. Limitations of the methodology include variability in proprietary manufacturing details and limited public disclosure for certain novel cyclization technologies, which can constrain absolute transparency in some supplier assessments. Nonetheless, the triangulated approach provides a robust foundation for operational and strategic decision-making.

Synthesize technical, supply chain, and regulatory imperatives to capitalize on cyclic peptide advantages while managing operational and compliance risks

Cyclic peptides represent a strategic opportunity for cosmetic science, offering molecular-level advantages that can be translated into differentiated product claims when supported by rigorous characterization and appropriate regulatory positioning. The interplay of advanced synthesis techniques, heightened analytical expectations, and shifting trade dynamics means that success depends not only on selecting the right peptide architecture but also on choosing suppliers and partners capable of delivering documented, reproducible quality. As stakeholders adapt to tariff-driven supply considerations and region-specific regulatory regimes, resilience and documentation emerge as twin priorities across procurement and development functions.

In summary, organizations that integrate technical due diligence with proactive supplier engagement and evidence-based commercialization planning will be better positioned to harness the potential of cyclic peptide raw materials. Prioritizing analytical rigor, sustainable process choices, and collaborative supplier relationships will reduce downstream friction and unlock the capacity to bring peptide-enabled cosmetic innovations to market with confidence.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cosmetic Cyclic Peptide Raw Materials Market, by Peptide Type

  • 8.1. Disulfide Bonded
    • 8.1.1. Multi-Disulfide Bonded
    • 8.1.2. Single Disulfide Bonded
  • 8.2. Head To Tail Cyclization
  • 8.3. Side Chain Cyclization
  • 8.4. Stapled Peptides

9. Cosmetic Cyclic Peptide Raw Materials Market, by Grade

  • 9.1. Analytical Grade
  • 9.2. Cosmetic Grade
  • 9.3. Pharmaceutical Grade

10. Cosmetic Cyclic Peptide Raw Materials Market, by Form

  • 10.1. Liquid
  • 10.2. Solid
    • 10.2.1. Crystalline Powder
    • 10.2.2. Lyophilized Powder

11. Cosmetic Cyclic Peptide Raw Materials Market, by Application

  • 11.1. Anti-Aging
  • 11.2. Hair Growth
  • 11.3. Moisturization
  • 11.4. Skin Lightening
  • 11.5. Uv Protection

12. Cosmetic Cyclic Peptide Raw Materials Market, by End User

  • 12.1. Contract Manufacturers
  • 12.2. Cosmetic Manufacturers
  • 12.3. Dermatology Clinics
  • 12.4. Home Use

13. Cosmetic Cyclic Peptide Raw Materials Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Retail

14. Cosmetic Cyclic Peptide Raw Materials Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cosmetic Cyclic Peptide Raw Materials Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cosmetic Cyclic Peptide Raw Materials Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Cosmetic Cyclic Peptide Raw Materials Market

18. China Cosmetic Cyclic Peptide Raw Materials Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Bachem Holding AG
  • 19.6. BASF SE
  • 19.7. Croda International Plc
  • 19.8. Evonik Industries AG
  • 19.9. GenScript Biotech Corporation
  • 19.10. Givaudan S.A.
  • 19.11. Koninklijke DSM N.V.
  • 19.12. Merck KGaA
  • 19.13. PolyPeptide Group Holdings S.A.
  • 19.14. The Lubrizol Corporation
  • 19.15. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY MULTI-DISULFIDE BONDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY MULTI-DISULFIDE BONDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY MULTI-DISULFIDE BONDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SINGLE DISULFIDE BONDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SINGLE DISULFIDE BONDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SINGLE DISULFIDE BONDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HEAD TO TAIL CYCLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HEAD TO TAIL CYCLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HEAD TO TAIL CYCLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SIDE CHAIN CYCLIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SIDE CHAIN CYCLIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SIDE CHAIN CYCLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY STAPLED PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY STAPLED PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY STAPLED PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ANALYTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ANALYTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ANALYTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COSMETIC GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COSMETIC GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PHARMACEUTICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PHARMACEUTICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY CRYSTALLINE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY CRYSTALLINE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY CRYSTALLINE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HAIR GROWTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HAIR GROWTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HAIR GROWTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY MOISTURIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY MOISTURIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY MOISTURIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SKIN LIGHTENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SKIN LIGHTENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SKIN LIGHTENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY UV PROTECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY UV PROTECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY UV PROTECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY CONTRACT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COSMETIC MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COSMETIC MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COSMETIC MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 171. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 173. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 174. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 198. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 199. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 200. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 201. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. G7 COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 207. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 209. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 210. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY PEPTIDE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISULFIDE BONDED, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY GRADE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY SOLID, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA COSMETIC CYCLIC PEPTIDE RAW MATERIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)